We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > IDT

News List

Valneva and IDT Biologika Announce Collaboration for Production of Inactivated COVID-19 Vaccine VLA2001 AmericanPharmaceuticalReview
December 02, 2021
Valneva a specialty vaccine company, and IDT Biologika announced their collaboration for the production of Valneva’s inactivated COVID-19 vaccine candidate VLA2001. This follows last week’s announcement that Valneva signed an Advance Purchase Agreement...
Takeda and IDT Support Manufacturing of J&J’s COVID-19 Vaccine contractpharma
March 16, 2021
Takeda Pharmaceutical has entered a mutual agreement with IDT Biologika GmbH, a contract development and manufacturing organization (CDMO), to utilize capacity at IDT previously reserved for Takeda’s dengue vaccine candidate (TAK-003) to manufacture ...
IDT Biologika Awarded New NIH Task Order contractpharma
July 18, 2019
Part of 10-year NIH contract to manufacture vaccines and biologics for infectious diseases.
NIH grants IDT 10-year vaccine manufacturing contract fiercepharma
December 04, 2018
IDT Biologika has won a 10-year contract worth up to $80 million from the NIH’s National Institute of Allergy and Infectious Diseases to make vaccines and biologics for infectious diseases.